My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
scPharmaceuticals Inc. - Common Stock
(NQ:
SCPH
)
5.670
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Oct 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
5.670
Bid (Size)
5.660 (17)
Ask (Size)
5.760 (2)
Prev. Close
5.670
Today's Range
5.670 - 5.670
52wk Range
1.940 - 6.280
Shares Outstanding
35,769,073
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZIMV, ARIS, SCPH on Behalf of Shareholders
September 16, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH
September 16, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
YTD
+58.8%
+58.8%
1 Month
+0.9%
+0.9%
3 Month
+16.7%
+16.7%
6 Month
+120.6%
+120.6%
1 Year
+28.6%
+28.6%
More News
Read More
Earnings Scheduled For August 7, 2025
August 07, 2025
Via
Benzinga
Insights Ahead: scPharmaceuticals's Quarterly Earnings
May 13, 2025
Via
Benzinga
Unusual volume stocks in Friday's session
August 29, 2025
Via
Chartmill
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMXI, HBI, VTLE, SCPH on Behalf of Shareholders
August 28, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: scPharmaceuticals Inc. (Nasdaq – SCPH), Vital Energy, Inc. (NYSE – VTLE), International Money Express, Inc. (Nasdaq - IMXI), HanesBrands Financial Corp. (NYSE - HBI)
August 28, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
SCPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of scPharmaceuticals Inc. - SCPH
August 26, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTLE and SCPH on Behalf of Shareholders
August 26, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
MannKind’s $360M scPharma Deal Splits Analysts — Retail Traders Call It ‘Bizarro Territory’ But Stay Bullish
August 25, 2025
Via
Stocktwits
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
August 25, 2025
Via
Benzinga
SCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of scPharmaceuticals Inc. Is Fair to Shareholders
August 25, 2025
From
Halper Sadeh LLC
Via
Business Wire
Which stocks are moving before the opening bell on Monday?
August 25, 2025
Via
Chartmill
Shareholder Alert: The Ademi Firm Investigates Whether scPharmaceuticals Inc. Is Obtaining a Fair Price for Its Public Shareholders
August 25, 2025
From
Ademi & Fruchter LLP
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 25, 2025
Via
Benzinga
MannKind Corporation to Acquire scPharmaceuticals: More Details Inside
August 25, 2025
Via
Stocktwits
MannKind to Acquire scPharmaceuticals, Accelerating Revenue Growth and Emerging as a Patient-Centric Leader in Cardiometabolic and Lung Diseases
August 25, 2025
From
MannKind
Via
GlobeNewswire
SCPH Revenue Up 99%
August 07, 2025
Via
The Motley Fool
Which stocks are moving before the opening bell on Tuesday?
April 22, 2025
Via
Chartmill
Analyst Expectations For scPharmaceuticals's Future
March 20, 2025
Via
Benzinga
scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 19, 2025
From
scPharmaceuticals Inc.
Via
GlobeNewswire
Earnings Scheduled For May 14, 2025
May 14, 2025
Via
Benzinga
Earnings Scheduled For March 19, 2025
March 19, 2025
Via
Benzinga
Wondering what's happening in today's after-hours session?
March 06, 2025
Via
Chartmill
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
March 06, 2025
From
scPharmaceuticals Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is scPharmaceuticals Inc. - Common Stock publicly traded?
Yes, scPharmaceuticals Inc. - Common Stock is publicly traded.
What exchange does scPharmaceuticals Inc. - Common Stock trade on?
scPharmaceuticals Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for scPharmaceuticals Inc. - Common Stock?
The ticker symbol for scPharmaceuticals Inc. - Common Stock is SCPH on the Nasdaq Stock Market
What is the current price of scPharmaceuticals Inc. - Common Stock?
The current price of scPharmaceuticals Inc. - Common Stock is 5.670
When was scPharmaceuticals Inc. - Common Stock last traded?
The last trade of scPharmaceuticals Inc. - Common Stock was at 10/06/25 04:00 PM ET
What is the market capitalization of scPharmaceuticals Inc. - Common Stock?
The market capitalization of scPharmaceuticals Inc. - Common Stock is 202.81M
How many shares of scPharmaceuticals Inc. - Common Stock are outstanding?
scPharmaceuticals Inc. - Common Stock has 203M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.